Delivery of Monoclonal Antibodies

This tender is for the supply of monoclonal antibodies. Monoclonal antibodies are highly specific proteins produced by identical immune cells that are clones of a unique parent cell, designed to target specific antigens. Their applications are widespread, particularly in medical diagnostics and therapeutics, including cancer treatment, autoimmune disease management, and infectious disease detection. The tender likely specifies the types, quantities, purity standards, and delivery requirements for these antibodies. The contracting authority, presumably a healthcare provider, research institution, or pharmaceutical company, requires a reliable source for these critical biological agents. The procurement aims to ensure the availability of high-quality monoclonal antibodies for research, diagnostic, or therapeutic purposes. Bidders will need to demonstrate their ability to meet stringent quality control measures and provide consistent supply. The specific intended use of the antibodies will dictate the precise technical specifications and regulatory compliance required.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals, Infectious Diseases and Laboratory. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of BGN 10,300.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.